Cancer Policy: Pharmaceutical Safety

1. Front Matter

   Pages i-v

   PDF

2. Impact of Cost on the Safety of Cancer Pharmaceuticals

   • Karen Fitzner, Frederick Oteng-Mensah

   Pages 1-20

3. Cancer Comorbidity: Implications for Drug Safety

   • Katherine O’Brien, June M. McKoy, Frank Penedo

   Pages 21-35

4. Pharmacovigilance of Alternative Medications in the Cancer Setting

   • Dustin B. Liebling, Emmanuel Cordova, Gary Deng, June M. McKoy

   Pages 37-45

5. Key Elements in Adverse Drug Reactions Safety Signals: Application of Legal Strategies

   • Brian Chen, John Restaino, Elizabeth Tippett

   Pages 47-59

6. Biosimilars: Are They Really Safe?

   • June M. McKoy, Frank J. Giles

   Pages 61-73

7. The Drug Shortage Crisis in the United States: Impact on Cancer Pharmaceutical Safety

   • Narissa J. Nonzee, Thanh Ha Luu

   Pages 75-92

8. Anatomy of Risk Evaluation and Mitigation Strategies (REMS)

   • Kari K. Loeser, June M. McKoy, Glen T. Schumock

   Pages 93-105

9. Cancer Drug Toxicity: Moving from Patient to Survivor

   • Megan Slocum, Sophie F. Garcia, June M. McKoy

   Pages 107-118

10. Moonshot to Cancer Cure: Recruiting Policy to Break Down Silos

    • Melissa Simon, Emmanuel Cordova, June M. McKoy

    Pages 119-128

Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating to drug safety in the cancer domain. Topics include natural language processing and pharmacovigilance of alternative cancer pharmaceuticals. The information presented in this volume will improve understanding of emerging strategies to identify adverse drug reactions and drug-drug interactions within the cancer setting and will highlight policies that have been instituted to improve cancer patient safety. In summary, Cancer Policy: Pharmaceutical Safety explores many of the important areas of pharmacovigilance research in oncology.

• Drug Safety
• Health
• Oncology
• Pharmaceutical
• Policy
• Toxicity

• Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, USA

  June M. McKoy

• Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, USA

  Dennis P. West

Policies and ethics